December 30, 2025

Merus N.V. (MRUS) Stock Analysis: Exploring a 7.78% Potential Upside in Biotechnology

Merus N.V. (MRUS), a prominent player in the biotechnology industry, offers an intriguing opportunity for investors seeking to navigate the complex landscape of healthcare innovation. Headquartered..

MiMedx Group, Inc. (MDXG) Stock Analysis: Unveiling a 76% Potential Upside in the Biotech Sector

MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology sector, is currently capturing investor attention with a potential upside of 76.56%, as indicated by..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare Challenges with a Robust Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the health information services sector, continues to navigate the complexities of the U.S. healthcare industry with a focus..

Ardent Health, Inc. (ARDT) Stock Analysis: A 52.53% Potential Upside Amid Healthcare Sector Dynamics

Ardent Health, Inc. (NYSE: ARDT) presents a compelling opportunity for investors seeking value in the healthcare sector, with a standout potential upside of 52.53%. Based in..

Catalyst Pharmaceuticals, Inc. (CPRX) Investor Outlook: Unveiling a Promising 44.88% Upside

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a prominent player in the biotechnology sector, is making waves with its strategic focus on rare diseases. Headquartered in Coral Gables,..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring an 8.20% Upside Potential

Healthcare Services Group, Inc. (HCSG), a prominent player in the healthcare sector, is making waves with its significant presence in medical care facilities across the United..

Tarsus Pharmaceuticals (TARS) Investor Outlook: Strong Buy Ratings and Promising Revenue Growth in Biotech

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a trailblazer in the biopharmaceutical sector, is making waves in the healthcare industry with its cutting-edge therapeutic developments. Headquartered in Irvine,..

Viridian Therapeutics (VRDN) Investor Outlook: A Biotech Pioneer with 30.79% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a dynamic player in the biotechnology sector, has been capturing investor attention with its promising developments in the treatment of serious..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Strong Revenue Growth and Bullish Analyst Ratings

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical leader in the healthcare sector, is catching the attention of investors with its robust revenue growth and favorable analyst..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A 104.98% Potential Upside with Strong Buy Ratings

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is making waves with its innovative therapeutic antibodies aimed at addressing severe inflammatory, allergic,..

Denali Therapeutics Inc. (DNLI) Investor Outlook: Unveiling a 94% Potential Upside in Biotechnology

Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing the attention of investors within the biotechnology sector, thanks to a remarkable potential upside of 94.30% as indicated by..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Gem with 24.74% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out in the biotechnology sector with its impressive growth metrics and a robust pipeline of biopharmaceutical assets. Based in Jupiter,..

ANI Pharmaceuticals, Inc. (ANIP) Investor Outlook: Exploring a Promising 34% Upside Potential

Investors eyeing the healthcare sector might want to give ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) a closer look. This biopharmaceutical company, headquartered in Baudette, Minnesota, is making..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Report: Analyzing a Potential 259.79% Upside Amidst Innovative Biotech Developments

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a compelling focus for investors interested in the biotechnology sector. With its current market cap at $1.9 billion and..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: A 19% Upside Awaits in the Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands out in the biotechnology sector with its innovative approach to diagnosing and treating diseases through its immune medicine platform. Headquartered..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring the 98% Potential Upside in Biotechnology

Dyne Therapeutics, Inc. (NASDAQ: DYN) has garnered significant attention in the biotechnology sector, thanks to its promising therapeutic pipeline and a striking potential upside of nearly..

Innoviva, Inc. (INVA) Stock Analysis: Unveiling a 64.81% Potential Upside

Innoviva, Inc. (NASDAQ: INVA) is capturing investor attention with a promising potential upside of 64.81%, as indicated by its average target price of $32.50. The biotechnology..

U.S. Physical Therapy, Inc. (USPH): Exploring the 29.37% Potential Upside and Analyst Optimism

Investors looking to capitalize on growth opportunities within the healthcare sector might want to consider U.S. Physical Therapy, Inc. (NYSE: USPH). With a market capitalization of..

MannKind Corporation (MNKD): Analyst Consensus Signals a 66.57% Upside Potential

MannKind Corporation (NASDAQ: MNKD), a prominent player in the healthcare sector specializing in biotechnology, is drawing considerable investor interest due to its promising growth trajectory and..

Teladoc Health, Inc. (TDOC) Stock Analysis: Assessing the 32% Potential Upside

Teladoc Health, Inc. (TDOC) stands as a pioneer in the burgeoning field of virtual healthcare services, offering a comprehensive suite of medical and mental health solutions..

Search

Funds

December 30, 2025

Search

Funds

December 30, 2025

FTSE 100

Funds